Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model

World Journal of Gastroenterology

Volumn 14, Issue 39, 2008, Pages 6036-6043

  Tsujimoto, Tatsuhiro ^a   Kawaratani, Hideto ^a   Kitazawa, Toshiyuki ^a   Hirai, Toshiko ^a   Ohishi, Hajime ^a   Kitade, Mitsuteru ^a   Yoshiji, Hitoshi ^a   Uemura, Masahito ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Contrast enhanced ultrasonography; Kupffer cells; Levovist; Nonalcoholic steatohepatitis; Phagocytic activity; Ultrasound contrast agent

Indexed keywords

SHU 508; ALANINE AMINOTRANSFERASE; CONTRAST MEDIUM; MICROSPHERE; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL FUNCTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER PARENCHYMA; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHAGOCYTOSIS; RAT; ANIMAL; BLOOD; CELL CULTURE; DISEASE MODEL; FATTY LIVER; FISCHER 344 RAT; HEPATITIS; LIVER; MASS SCREENING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALANINE TRANSAMINASE; ANIMALS; CELLS, CULTURED; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATITIS; KUPFFER CELLS; LIVER; MALE; MASS SCREENING; MICROSPHERES; PHAGOCYTOSIS; POLYSACCHARIDES; RATS; RATS, INBRED F344;

EID: 59849085131     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6036     Document Type: Article

References (29)

1. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001; 51: 127-131
2. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002; 37: 154-160
3. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140
4. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845
5. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419
6. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474
7. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16
8. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004; 24: 3-20
9. Moriyasu F, Iijima H, Tsuchiya K, Miyata Y, Furusaka A, Miyahara T. Diagnosis of NASH using delayed parenchymal imaging of contrast ultrasound. Hepatol Res 2005; 33: 97-99
10. Nakae D, Mizumoto Y, Yoshiji H, Andoh N, Horiguchi K, Shiraiwa K, Kobayashi E, Endoh T, Shimoji N, Tamura K. Different roles of 8-hydroxyguanine formation and 2-thiobarbituric acid-reacting substance generation in the early phase of liver carcinogenesis induced by a choline-deficient, L-amino acid-defined diet in rats. Jpn J Cancer Res 1994; 85: 499-505
11. Seglen PO. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391-398
12. Kubo S, Rodriguez T Jr, Roh MS, Oyedeji C, Romsdahl MM, Nishioka K. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin. Hepatology 1994; 19: 1044-1049
13. Tsujimoto T, Kuriyama S, Yoshiji H, Fujimoto M, Kojima H, Yoshikawa M, Fukui H. Ultrasonographic findings of amebic colitis. J Gastroenterol 2003; 38: 82-86
14. Matsuda Y, Yabuuchi I. Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 1986; 161: 701-705
15. Kudo M, Tomita S, Tochio H, Kashida H, Hirasa M, Todo A. Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology 1991; 179: 377-382
16. Harvey CJ, Blomley MJ, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000; 355: 807-808
17. Vallone P, Gallipoli A, Izzo F, Fiore F, Delrio P. Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results. Anticancer Res 2003; 23: 5075-5079
18. Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, Lee JY, Jeon YH, Lee J, Lee SJ, Lim JH. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56: 66-73
19. Maruyama H, Matsutani S, Kondo F, Yoshizumi H, Kobayashi S, Okugawa H, Ebara M, Saisho H. Ring-shaped appearance in liver-specific image with Levovist: a characteristic enhancement pattern for hypervascular benign nodule in the liver of heavy drinkers. Liver Int 2006; 26: 688-694
20. Iijima H, Moriyasu F, Miyahara T, Yanagisawa K. Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies. Hepatol Res 2006; 35: 235-237
21. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007; 33: 318-325
22. Toft KG, Hustvedt SO, Hals PA, Oulie I, Uran S, Landmark K, Normann PT, Skotland T. Disposition of perfluorobutane in rats after intravenous injection of Sonazoid. Ultrasound Med Biol 2006; 32: 107-114
23. Quaia E, Blomley MJ, Patel S, Harvey CJ, Padhani A, Price P, Cosgrove DO. Initial observations on the effect of irradiation on the liver-specific uptake of Levovist. Eur J Radiol 2002; 41: 192-199
24. Lim AK, Patel N, Eckersley RJ, Goldin RD, Thomas HC, Cosgrove DO, Taylor-Robinson SD, Blomley MJ. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006; 240: 130-135
25. Blomley MJ, Albrecht T, Cosgrove DO, Eckersley RJ, Butler-Barnes J, Jayaram V, Patel N, Heckemann RA, Bauer A, Schlief R. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999; 25: 1341-1352
26. Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, Sasaki S, Nishiguchi S, Maeyama S. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res 2007; 37: 722-730
27. Tsujimoto T, Kuriyama S, Yamazaki M, Nakatani Y, Okuda H, Yoshiji H, Fukui H. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int J Oncol 2001; 18: 41-47
28. Eastin CE, McClain CJ, Lee EY, Bagby GJ, Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin Exp Res 1997; 21: 1037-1041
29. Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000; 32: 3-10